SwingTrade Member Forum

[Rawnoc]

REPR 1/16/09 update:

REPR -- profitable, rapidly growing, recession-proof, tiny float OS & market cap....

(1) After turning the corner of profitability a few of quarters ago, sales and net income are starting to blow up, with Operational cashflow last quarter was +$311,000, bringing their cash position from $158k to $349k, bringing their balance sheet to positive book value for the first time.
http://tinyurl.com/8o859z

(2) REPR forecasts their quarterly performance to accelerate:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34871342

(3) Several trader shows were attended and new distributors trained late last quarter:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34875177

(4) Medicare reimbursement for the Freedom60 (their biggest & most exciting revenue-generating product) was increased 20 fold in June of 2007 and is the ONLY infusion pump accepted by Medicare for reimbursement for Subcutaneous Immune Globulin treatment (Vivaglobin):
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776642
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776847

(5) Products are recession-proof with no direct competition with sales rapidly expanding due to a new treatment (Vivaglobin) where their infusion pump is the best, cheapest, safest, and most convenient form of delivery:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28775119
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28777209
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28838178

(6) They are hiring like crazy:
http://www.rmsmedicalproducts.com/Careers.htm
http://investorshub.advfn.com/boards/read_msg.asp?message_id=24616830

(7) Additional products are being released this year as well as more products are in development.

Based on last Q, REPR is growing so fast with such large margins that I think they are 1 or 2 quarters away from +.02 EPS per quarter or more or an annualized +.08 EPS pace IMO. Possibly 2-3 quarters away from +.03 EPS per Q or an annualized +.12 EPS. A mere 15 PE with rapid recession-proof growth = $1.80/share.

More REPR INFO and Board:
http://investorshub.advfn.com/boards/board.aspx?board_id=201